2010•Practical Journal of Cardiac Cerebral Pneumal and Vascular DiseaseRequires access

Irbesartan Hydrochlorothiazide Clinical Efficacy of Treatment of Essential Hypertension

Zhong Yong-hu

Open publisher page 0 citations

Abstract

Objective To discuss clinical the treatment efficacy of the effects of irbesartan and Irbesartan Hydrochlo-rothiazide tablets to primary hypertension. Methods Divided 180 patients of primary hypertension into two groups with control group 90 cases and treatment group 90 cases from August 2007 to April 2009 in our hospital randomly. The observation group were treated with irbesartan hydrochlorothiazide tablets and control group were treated with irbesartan. Course of treatment was 8 weeks,and observed effects after 4 weeks and 8 weeks. Results The total effective rate was 90. 5% of observation group,and 85. 4% of control group. total effective rate was significant difference ( P 0. 05) . Conclusion The effect of Irbesartan Hydrochlorothiazide tablets were significantly superior to irbesartan. It is worthy of reference.

About this research paper

What this paper is about

Objective To discuss clinical the treatment efficacy of the effects of irbesartan and Irbesartan Hydrochlo-rothiazide tablets to primary hypertension. Methods Divided 180 patients of primary hypertension into two groups with control group 90 cases and treatment group 90 cases from August 2007 to April 2009 in our hospital randomly. The observation group were treated with irbesartan hydrochlorothiazide tablets and control group were treated with irbesartan. Course of treatment was 8 weeks,and observed effects after 4 weeks and 8 weeks. Results The total effective rate was 90. 5% of observation group,and 85. 4% of control group. total effective rate was significant difference ( P 0. 05) . Conclusion The effect of Irbesartan Hydrochlorothiazide tablets were significantly superior to irbesartan. It is worthy of reference.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To discuss clinical the treatment efficacy of the effects of irbesartan and Irbesartan Hydrochlo-rothiazide tablets to primary hypertension. Methods Divided 180 patients of primary hypertension into two groups with control group 90 cases and treatment group 90 cases from August 2007 to April 2009 in our hospital randomly. The observation group were treated with irbesartan hydrochlorothiazide tablets and control group were treated with irbesartan. Course of treatment was 8 weeks,and observed effects after 4 weeks and 8 weeks. Results The total effective rate was 90. 5% of observation group,and 85. 4% of control group. total effective rate was significant difference ( P 0. 05) . Conclusion The effect of Irbesartan Hydrochlorothiazide tablets were significantly superior to irbesartan. It is worthy of reference.

Key concepts: Irbesartan, Medicine, Hydrochlorothiazide, Clinical efficacy, Urology, Internal medicine, Pharmacology, Blood pressure

Related papers

Back to paper searchBrowse research topicsOriginal source
Irbesartan Hydrochlorothiazide Clinical Efficacy of Treatment of Essential Hypertension — Research Paper | ScholarLens